Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xenidate XL 36mg tablets
0404000M0BIACAN
|
Xenidate | Methylphenidate hydrochloride | Central Nervous System | 3,234 |
|
Xenidate XL 54mg tablets
0404000M0BIADAR
|
Xenidate | Methylphenidate hydrochloride | Central Nervous System | 2,888 |
|
Xenidate XL 18mg tablets
0404000M0BIAAAM
|
Xenidate | Methylphenidate hydrochloride | Central Nervous System | 2,278 |
|
Xenidate XL 27mg tablets
0404000M0BIAEAT
|
Xenidate | Methylphenidate hydrochloride | Central Nervous System | 1,432 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.